期刊文献+

人乳头状瘤病毒感染物理与药物治疗临床分析 被引量:3

Clinical comparative analysis of physical therapy and medicine therapy in treating HPV infection
原文传递
导出
摘要 目的分析物理与药物治疗人乳头状瘤病毒(HPV)感染的临床效果,为临床选择合适的治疗方案提供参考依据。方法选取2013年9月-2015年9月医院收治的宫颈糜烂HPV感染患者160例,随机分为观察组与对照组,各80例;观察组采用物理治疗方案进行治疗,对照组采用药物治疗方案进行治疗,观察治疗3个月后临床效果,数据采用SPSS 19.0软件进行统计分析。结果观察组治疗有效率为97.50%、对照组为86.25%;观察组白带量多治疗改善率为97.50%,白带脓性治疗改善率为98.75%,对照组白带量多治疗改善率为88.75%,白带脓性治疗改善率为88.75%,观察组治疗改善率明显高于对照组,差异均有统计学意义(P<0.05)。结论物理治疗HPV感染临床治疗效果显著,且临床症状改善明显,HPV转阴率高,值得临床推广。 OBJECTIVE To analyze clinical effect of physical therapy and drug therapy in treating human papilloma virus(HPV)infection,so as to provide the clinical basis to select the appropriate treatment regimen clinically.METHODS Totally 160 cases with HPV infection admitted from Sept.2013 to Sept.2015 were randomly divided into observation group and control group with 80 cases each.The observation group was treated with physical therapy,while the control group was treated with drugs.The clinical effects were compared after three months.SPSS 19.0 was explored for statistical analysis.RESULTS The effective rate was 97.50% in the observation group,and was 86.25 in the control group.The improvement rate of curing heavy leucorrhea was 97.50%in the observation group and was 88.75%in the control group.The improvement rate of curing purulent leucorrhea was98.75% of the observation group and 88.75% of the control group.The improvement rates of the observation group were sighificently higher than those of the control group(P〈0.05).CONCLUSION Physical therapy can better cure HPV infections clinically with obliviously improved clinical symptoms,higher HPV negative conversion rate,hence is worthy to be promoted clinically.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第8期1857-1859,共3页 Chinese Journal of Nosocomiology
基金 湖北省卫生厅基金资助项目(WJ01564)
关键词 人乳头状瘤病毒 感染 物理治疗 药物治疗 Human papilloma virus Infection Physiotherapy Medical treatement
  • 相关文献

参考文献8

  • 1Ye Y,Xu W,Zhong W,et al.Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6down-regulation and caspases activation[J].Mol Cell Biochem,2012,363(2):191-202.
  • 2Wikstrm A,Hedblad MA,Syrjnen S.Penile intraepithelial neoplasia:histopathological evaluation,HPV typing,clinical presentation and treatment[J].J Eur Acad Dermatol Venereol,2012,26(3):325-330.
  • 3Conesa-Zamora P.Immune responses against virus and tumor in cervical carcinogenesis:treatment strategies for avoiding the HPV-induced immune escape[J].Gynecol Oncol,2013,131(2):480-488.
  • 4Wang HW,Zhang LL,Miao F,et al.Treatment of HPV infection-associated cervical condylomata acuminata with 5-aminolevulinic acid-mediated photodynamic therapy[J].Photochem Photobiol,2012,88(3):565-569.
  • 5Sauer AG,Jemal A,Simard EP,et al.Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States,2008-2013[J].Cancer Epidemiol,2015,39(4):650-655.
  • 6Ronco G,Dillner J,Elfstrm KM,et al.Efficacy of HPV-based screening for prevention of invasive cervical cancer:follow-up of four European randomised controlled trials[J].Lancet,2014,383(9916):524-532.
  • 7杜蓉,陈志芳,韩英,丁岩.人乳头瘤病毒分型检测在不同年龄CINⅡ~Ⅲ患者LEEP治疗后随访的临床研究[J].实用妇产科杂志,2012,28(3):226-229. 被引量:31
  • 8Srensen BS,Busk M,Horsman MR,et al.Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models[J].Anticancer Res,2014,34(11):6297-6304.

二级参考文献10

  • 1Massad LS, Collins YC, Meyer PM. et al Biopsy correlates of abnor- mal cervical cytology classified using the bethesda system[ J]. Gyne- cologic Oncology, 2001, 82 ( 3 ) :516 - 522.
  • 2Walboomers JM, Jacobs MV, Manos MM, et al. Human papiUomavir- us is a necessary cause of invasive cervical cancer worldwide [ J ]. J Pathol, 1999, 189( 1 ) : 12 - 19.
  • 3Von Keyserling H, Kaufmann AM, Schneider A. HPV testing in the follow- up after treatment of women with CIN [ J]. Gynecol Oncol, 2007, 107( 1 ) Suppl 1 :S5 - S7.
  • 4Aerssens A, Claeys P, Beerens E, et al. Prediction of recurrent dis- ease by cytology and HPV testing after treatment of cervical intraepi- thelial neoplasia[ J]. Cytopathology, 2009,20(1) :27 -35.
  • 5Kang WD, Oh M J, Kim SM, et al Significance of human papilloma- virus genotyping with high - grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure[ J]. Am J Obstet Gynecol, 2010, 203( 1 ) :72. e1 -6.
  • 6Lindeque BG. , Management of cervical premalignant lesions [ J ]. Best Pract Res Clin Obstet Gynaecol, 2005,19(4) :545 -561.
  • 7Aerssens A, Claeys P, Garcia A, et al. Natural history and clearance of HPV after treatment of precancerous cervical lesions [ J ]. Histopa- thology,2008,52(3) :381 - 386.
  • 8Para Skevaidi SE, Arbyn M, Sotiriadis A, et al. The role of HPV DNA testing in the follow-up period after treatment for CIN:A systematic re- view of theliterature[ J]. Cancer Treat Rew,2004,30(2) :205 -211.
  • 9Molano M, Van den Brule A, Plummer M, et al. Determinants of clear- ance of human papillomavirus infections in Colombian women with normal cytology : a population-based, 5-year follow-up study [ J ]. AmJ Epidemio1,2003,158 (5) :486 - 494.
  • 10Cox JT. History of use of HPV testing in cervical screening and in the management of abnormal cervical screening results [ J ]. Journal of clinical Virology ,2009,45 ( suppl 1 ) :S3 - S12.

共引文献30

同被引文献37

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部